Oral semaglutide tablets represent a significant shift in weight loss treatment, allowing patients to take GLP-1 medication without injections
It is typically most pronounced during the first 1 to 2 weeks of each dose escalation and tends to improve with continued use
If five or more days have passed, skip it and take the next dose on your regular day
Website Reference: Prevalence of Obesity. World Obesity Health Risks of Being Overweight. NIDDK, U.S
Historically, obesity medications have received limited provincial coverage, though this may change as the evidence base for these treatments strengthens
Any product sold online or by a compounding pharmacy as "retatrutide" is, at best, a research chemical of uncertain identity and purity, and at worst what the FDA called out in its May 2026 warning letter unapproved drug products misbranded for human use